Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q1 2018 · —
Revenue$2.38B$2.38B+8.1% vs Q1 2017 Net Income$298.00M$298.00M+2.8% vs Q1 2017 EPS Diluted$0.21$0.21±0.0% vs Q1 2017 Gross Profit$1,707,000,000+13.0% Operating Income$407,000,000+11.8% Operating Cash Flow$193,000,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
N/M
Free Cash Flowderived$133,000,000N/M Margins · derivedGross margin71.8%+3.1 pt vs Q1 2017
Operating margin17.1%+0.6 pt vs Q1 2017
Net margin12.5%−0.6 pt vs Q1 2017